U.S. Patents Awarded to Inventors in California (Feb. 9)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Feb. 9 -- The following federal patents were awarded to inventors in California.

*** Advanced Cardiovascular Systems Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Advanced Cardiovascular Systems, Santa Clara, Calif., has been assigned a patent (8,366,762) developed by Syed F. A. Hossainy, Fremont, Calif., and David C. Gale, San Jose, Calif., for a "method of making a medical device with regioselective structure-property distribution." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A medical device and methods of making the medical device such as a stent having selected regions with different material properties than other regions are disclosed. Selection and modification of the regions may be based on facilitating a desired mechanical behavior and/or therapeutic prophylactic property of the device." The patent application was filed on June 8, 2010 (12/796,543). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,762.PN.&OS=PN/83,66,762&RS=PN/83,66,762 Written by Amal Ahmed; edited by Jaya Anand.

*** Abbott Diabetes Care Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Abbott Diabetes Care, Alameda, Calif., has been assigned a patent (8,366,730) developed by Samuel Mason Curry, Oakland, Calif., and Ray Adams Lathrop, Atlanta, for a "cocking mechanism for lancing device." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A lancing device is disclosed in which cocking of the lancet holder is achieved in response to retraction of a push member. A lancing device is also disclosed in which a lancet storage compartment is provided in the housing of the lancing device and closing movement of a closure member for the storage compartment has the effect of cocking the lancet holder. Methods of cocking lancing devices are also disclosed." The patent application was filed on Aug. 31, 2011 (13/222,242). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,730.PN.&OS=PN/83,66,730&RS=PN/83,66,730 Written by Amal Ahmed; edited by Jaya Anand.

*** Cutera Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Cutera, Brisbane, Calif., has been assigned a patent (8,366,703) developed by Scott A. Davenport, Half Moon Bay, Calif., and David A. Gollnick, San Francisco, for a "fractional scanner for dermatological treatments." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A dermatological treatment device is disclosed for generating a matrix of two dimensional treatment spots on the tissue. A handpiece carrier a laser which generates a beam of laser pulses. The pulses are focused onto the tissue with a lens system. A diffractive element is positioned between the laser and the lens system for splitting the laser beam into a plurality of sub-beams. A scanner translates the beam over the diffractive element to generate the two dimensional spot pattern. The laser has a semi-monolithic resonator design with one integral end mirror defining the output coupler and a second, independent mirror for adjustment." The patent application was filed on March 16, 2009 (12/405,085). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,703.PN.&OS=PN/83,66,703&RS=PN/83,66,703 Written by Amal Ahmed; edited by Jaya Anand.

*** AT&T Intellectual Property II Assigned Patent for Method and Apparatus for Determining a Direct Measure of Quality in a Packet-switched Network ALEXANDRIA, Va., Feb. 9 -- AT&T Intellectual Property II, Atlanta, has been assigned a patent (8,369,230) developed by Marian Croak, Fair Haven, N.J., and Hossein Eslambolchi, Los Altos Hills, Calif., for a "method and apparatus for determining a direct measure of quality in a packet-switched network." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and system for analyzing deficiencies in a packet-switched network is described. In one example, network measurement data pertaining to components within a packet-switched network are obtained. Reliability estimates of access networks and associated access links coupled to the packet-switch network are conducted. Lastly, an end-to-end direct measure of quality (DMOQ) is calculated from the network measurement data and network estimation data derived from the reliability estimates." The patent application was filed on Dec. 22, 2004 (11/019,848). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,230.PN.&OS=PN/83,69,230&RS=PN/83,69,230 Written by Amal Ahmed; edited by Jaya Anand.

*** Rassman Licensing Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Rassman Licensing, Dover, Del., has been assigned a patent (8,366,723) developed by William R. Rassman, Los Angeles, and Jae P. Pak, Los Angeles, for a "hair harvesting device and method with localized subsurface dermal fluid insertion." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The stabilization of the dermal area around a follicular unit of hair for harvesting comprises the introduction of a small volume of fluid into the dermal area around a target follicular unit in order to stabilize the dermal area and initiate a limited time period during which the harvesting of the target follicular unit can occur." The patent application was filed on Sept. 18, 2008 (12/233,514). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,723.PN.&OS=PN/83,66,723&RS=PN/83,66,723 Written by Amal Ahmed; edited by Jaya Anand.

*** Broadcom Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Broadcom, Irvine, Calif., has been assigned a patent (8,369,252) developed by John Walley, Ladera Ranch, Calif., for a "method and system for time division duplex hum noise cancellation." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and systems for TDD hum noise cancellation are disclosed and may include correlating a received audio signal to a time division duplexed (TDD) envelope signal, controlling a feedback signal based on the correlating, and cancelling a TDD noise signal via the feedback signal. The amplitude and delay of the feedback signal may be configured for controlling. A least mean square (LMS) filter may be utilized for the correlating and may include a finite impulse response filter. The TDD envelope signal may be generated on the chip or may be received from a source external to the chip. The feedback signal may be added to the received audio signal for the cancelling." The patent application was filed on June 11, 2008 (12/137,256). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,252.PN.&OS=PN/83,69,252&RS=PN/83,69,252 Written by Amal Ahmed; edited by Jaya Anand.

*** Sony Computer Entertainment America Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Sony Computer Entertainment America, Foster City, Calif., has been assigned a patent (8,369,243) developed by Ken Miyaki, San Diego, for "minimizing bandwidth costs for online games." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Minimizing bandwidth cost for a participant in an online game, the method including: querying the game participant to determine a network service charge model; selecting a role for the game participant based on the determined network service charge model and a position of the participant in a network topology; and positioning the game participant into the selected role within the network topology of the online game." The patent application was filed on April 28, 2009 (12/431,236). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,243.PN.&OS=PN/83,69,243&RS=PN/83,69,243 Written by Amal Ahmed; edited by Jaya Anand.

*** Venetec International Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Venetec International, Covington, Ga., has been assigned a patent (8,366,678) developed by Steven F. Bierman, Del Mar, Calif., Richard A. Pluth, San Diego, and Wayne T. Mitchell, Cardiff, Calif., for a medical anchoring system.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "An anchoring system for an elongated medical article comprises an anchor pad and a retainer mounted upon the anchor pad. The retainer includes a base, a cover, and a compressible member including a receptacle into which the medical article to be retained is placed. When the cover is closed, the medical article is secured within the receptacle by the pressure of the compressible member and the cover upon the medical article. One or more biasing members act upon the compressible member to increase the frictional forces acting on the retained section of the medical article. The receptacle may form a channel that follows a curved path through the retainer. The retainer may also include guide extensions to support the medical article along a transverse bend toward the skin of the patient." The patent application was filed on Dec. 6, 2005 (11/295,903). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,678.PN.&OS=PN/83,66,678&RS=PN/83,66,678 Written by Amal Ahmed; edited by Jaya Anand.

*** Abbott Cardiovascular Systems Assigned Patent for Reperfusion Balloon Inflation Device ALEXANDRIA, Va., Feb. 9 -- Abbott Cardiovascular Systems, Santa Clara, Calif., has been assigned a patent (8,366,659) developed by Kevin J. Ehrenreich, San Francisco, and Jesus Magana, Redwood City, Calif., for a "reperfusion balloon inflation device." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An ischemic postconditioning system and related method comprising a catheter including a plurality of lumens and at least one expandable member with at least one chamber including a moveable plunger and a return mechanism operatively engaged with the plunger. The moveable plunger divides the at least one chamber into first and second volumes. A first pressure source is provided having a first fluid at a first pressure and is disposed in fluid communication with the first volume of the chamber. Further, a second pressure source is provided having a second fluid at a second pressure and is disposed in fluid communication with the second volume of the chamber. Similarly, the at least one expandable member is disposed in fluid communication with the second volume of the chamber. The first fluid supplied by the first pressure source displaces the plunger in a first direction delivering at least a portion of the second fluid into the at least one expandable member. Also, the return mechanism displaces the plunger in a second direction delivering the second fluid from the second pressure source to the second volume of the chamber." The patent application was filed on Feb. 23, 2011 (13/032,743). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,659.PN.&OS=PN/83,66,659&RS=PN/83,66,659 Written by Amal Ahmed; edited by Jaya Anand.

*** Ixia Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Ixia, Calabasas, Calif., has been assigned a patent (8,369,225) developed by four co-inventors for "network testing providing for concurrent real-time ingress and egress viewing of network traffic data." The co-inventors are Ethan Sun, Woodland Hills, Calif., Dean Lee, Woodland Hills, Calif., Rajesh Paramasivan, Thousand Oaks, Calif., and Victor Alston, Oak Park, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "There is disclosed a system and method for implementing concurrent real-time ingress and egress viewing of network traffic data to evaluate the performance of a device under test. The method may be performed by a network testing system." The patent application was filed on Sept. 23, 2009 (12/565,657). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,225.PN.&OS=PN/83,69,225&RS=PN/83,69,225 Written by Amal Ahmed; edited by Jaya Anand.

*** Net Optics Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Net Optics, Santa Clara, Calif., has been assigned a patent (8,369,218) developed by Eldad Matityahu, Palo Alto, Calif., Kai Liu, Fremont, Calif., and Stephen Strong, Fremont, Calif., for a zero-interrupt network tap.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A network tap monitors network information flow over a particular connection. By duplicating the signal and diverting a copy, the information flow can be analyzed, both in real time and without interference through the monitoring process. When the power to the tap is either turned on or off, however, the change in impedance in the tap's circuit can create an interference spike in the connection that interrupts the information flow. By reducing or eliminating the impedance change in the tap circuitry, such disruptive interruptions can be eliminated." The patent application was filed on April 28, 2004 (10/834,448). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,218.PN.&OS=PN/83,69,218&RS=PN/83,69,218 Written by Amal Ahmed; edited by Jaya Anand.

*** Medtronic MiniMed Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Medtronic MiniMed, Northridge, Calif., has been assigned a patent (8,366,666) developed by Colin A. Chong, Burbank, Calif., Julian D. Kavazov, Arcadia, Calif., and Eric M. Lorenzen, Granada Hills, Calif., for "reservoir pressure equalization systems and methods." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Various embodiments of the present invention are directed to equalizing pressure in a reservoir containing fluidic media, possibly due to imperfect installation of the reservoir or an external influence such as an altitude or a temperature change. In various embodiments, fluidic media may be expelled from the reservoir through a needle and contained in an interior volume of a pierceable member before the needle pierces the pierceable member to establish a flow path to a user. In other embodiments, fluidic media may be expelled through a port of the reservoir into a chamber. In further embodiments, fluidic media may be expelled through a channel in a plunger head and out a passage in the reservoir when the channel and passage are aligned. In other embodiments, fluidic media may be expelled through a valve, and the valve may be pierceable by a needle to establish a flow path to the user." The patent application was filed on March 2, 2012 (13/411,278). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,666.PN.&OS=PN/83,66,666&RS=PN/83,66,666 Written by Amal Ahmed; edited by Jaya Anand.

*** Stryker Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Stryker, Kalamazoo, Mich., has been assigned a patent (8,366,654) developed by Pajhand Iranitalab, Pleasanton, Calif., for an "apparatus for preventing cross contamination by sterilizing an insufflation device." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An insufflation device connects to a disposable tube set for providing gas to fill an abdominal cavity of a patient to enable surgical procedures. The insufflation device has an ultraviolet light source to provide ultraviolet light for sterilizing a flow control valve system therein. A filter provided with the insufflation device enables additional surgical procedures for the insufflation device without cleaning of the flow control valve systems or necessarily replacement of the filter. Tube sets connected to the insufflation device do not necessarily require a filter." The patent application was filed on Aug. 10, 2010 (12/806,300). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,654.PN.&OS=PN/83,66,654&RS=PN/83,66,654 Written by Amal Ahmed; edited by Jaya Anand.

*** Empire Technology Development Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Empire Technology Development, Wilmington, Del., has been assigned a patent (8,369,242) developed by Miodrag Potkonjak, Los Angeles, for an efficient location discovery.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Techniques are generally described for determining locations of a plurality of communication devices in a network. In some examples, methods for determining locations of a plurality of communication devices in a network may comprises formulating the determination as a quantitative problem based at least in part on one or more attributes between individual communication devices and one or more beacon nodes whose locations are known, wherein the quantitative problem is expressed in terms of an objective function, one or more constraints, and one or more models, and solving the quantitative problem to determine the location of at least a portion of the one or more communication devices, wherein the solving includes manipulation of at least the objective function, one of the one or more constraints or one of the one or more models. Additional variants and embodiments are also disclosed." The patent application was filed on March 31, 2009 (12/415,518). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,242.PN.&OS=PN/83,69,242&RS=PN/83,69,242 Written by Amal Ahmed; edited by Jaya Anand.

*** Satiogen Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Satiogen Pharmaceuticals, San Diego, has been assigned a patent (8,366,650) developed by Andrew Young, Rancho Santa Fe, Calif., for a "biliary/pancreatic shunt device and method for treatment of metabolic and other diseases." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided is a shunt device that promotes stimulation of secretion of intestinal L-cells and other enteroendocrine cell types. Enteroendocrine secretion is stimulated directly or indirectly by shunting bile and/or pancreatic secretion to segments of the gut more distal than would normally occur The shunt device may be a flexible catheter that is impervious to such secretions, with a proximal end draining the pancreatic/bile duct, and a distal end residing distally within the lumen of the small or large intestine. The shunt may be inserted with minimally invasive techniques, such as by endoscopy." The patent application was filed on Oct. 24, 2006 (12/084,069). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,650.PN.&OS=PN/83,66,650&RS=PN/83,66,650 Written by Amal Ahmed; edited by Jaya Anand.

*** Juniper Networks Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Juniper Networks, Sunnyvale, Calif., has been assigned a patent (8,369,224) developed by five co-inventors for "combining network endpoint policy results." The co-inventors are Roger Chickering, Granite Bay, Calif., Stephen R. Hanna, Bedford, Mass., Paul Funk, Cambridge, Mass., Panagiotis Kouriouris, Cupertino, Calif., and Paul James Kirner, Jamaica Plain, Mass.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "An endpoint integrity system controls access to resources of a protected network for endpoint devices attempting to access the protected network. The system may include a number of evaluation modules that communicate with an endpoint device. The evaluation modules generate policy results for the endpoint device, in which each of the policy results assume one of three or more states, called a multi-state policy result. The multi-state policy results are combined to produce a combined Boolean policy result." The patent application was filed on Sept. 8, 2006 (11/530,189). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,224.PN.&OS=PN/83,69,224&RS=PN/83,69,224 Written by Amal Ahmed; edited by Jaya Anand.

*** Spiracur Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Spiracur, Sunnyvale, Calif., has been assigned a patent (8,366,693) developed by six co-inventors for "methods and devices for applying closed incision negative pressure wound therapy." The co-inventors are Dean Hu, San Leandro, Calif., Kenton Fong, Mountain View, Calif., Moshe Pinto, Mountain View, Calif., Kenneth Wu, Mountain View, Calif., Craig McGreevy, Walnut Creek, Calif., and Brendan Donohoe, Fairfax, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A surgical tissue therapy device includes a sealant layer and a collection chamber. The sealant layer functions so as to create a sealed enclosure, or space between it and the surface of a patient, by forming an airtight seal around a surgical area of skin trauma. The closed incision tissue therapy device also comprises a collection chamber, which may comprise an elongate tubular chamber with a plurality of longitudinally spaced openings. The collection chamber may be configured to be in fluid communication with the sealant layer and the area of skin trauma and functions as to distribute the negative pressure applied to a surgically closed area of skin trauma. Preferably, the pressure under the sealant layer is reduced by expanding the volume of the enclosure space and thereby decreasing the density of air molecules under the sealant layer. The collection material may comprise a material and/or a configuration that permits length changes based upon the length of the corresponding surgical wound or incision." The patent application was filed on June 18, 2010 (12/818,459). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,693.PN.&OS=PN/83,66,693&RS=PN/83,66,693 Written by Amal Ahmed; edited by Jaya Anand.

*** CerviLenz Assigned Patent ALEXANDRIA, Va., Feb. 9 -- CerviLenz, Chagrin Falls, Ohio, has been assigned a patent (8,366,640) developed by five co-inventors for "devices and methods for cervix measurement." The co-inventors are Jonathan P. Bauer, Cincinnati, Dean R. Koch, Chagrin Falls, Ohio, Paul E. McCreadie, Ann Arbor, Mich., Michael Glenn Ross, Los Angeles, and Craig B. Berky, Milford, Ohio.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A device for measuring a length of a cervix includes an elongate measurement member, a hollow member, a flange, a handle, and a locking mechanism. The elongate measurement member extends along a longitudinal axis and includes a measurement scale thereon. The hollow member is coaxial with and disposed over the elongate measurement member. The flange is offset from the longitudinal axis and attached to a distal end of the hollow member. The handle is attached to a proximal end of the measurement member. The locking mechanism is configured, when locked, to fix the hollow member relative to the measurement member and, when unlocked to allow the hollow member to slide along the measurement member and rotate about the longitudinal axis so as to place the flange in a desired position without moving the measurement scale." The patent application was filed on Nov. 11, 2010 (12/944,580). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,640.PN.&OS=PN/83,66,640&RS=PN/83,66,640 Written by Amal Ahmed; edited by Jaya Anand.

*** Penumbra Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Penumbra, Alameda, Calif., has been assigned a patent (8,366,735) developed by four co-inventors for a "system and method for treating ischemic stroke." The co-inventors are Arani Bose, New York, Vikas Gupta, San Leandro, Calif., Sean Donahue, Half Moon Bay, Calif., and Delilah Hui, American Canyon, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A thromboembolic removal system for treating ischemic stroke includes an aspiration catheter and an elongate member having a separator on a distal portion of the elongate member. During use of the thromboembolic removal system, the aspiration catheter and elongate member are positioned in a blood vessel, with the elongate member extending through the lumen of the aspiration catheter. Vacuum is applied through the aspiration catheter and the separator is deployed distal to the aspiration catheter into contact with thromboembolic material within a blood vessel. Manipulation of the separator during aspiration can facilitate aspiration by loosening, separating, or softening pieces of thromboembolic material, by removing any clogs or flow restrictions within the lumen of the aspiration catheter, and/or by pushing or plunging loosened material towards and/or into the distal end of the aspiration catheter for subsequent aspiration out of the body." The patent application was filed on Aug. 24, 2005 (11/210,634). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,735.PN.&OS=PN/83,66,735&RS=PN/83,66,735 Written by Amal Ahmed; edited by Jaya Anand.

*** Cisco Technology Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Cisco Technology, San Jose, Calif., has been assigned a patent (8,369,219) developed by Dipankar Bhatt Acharya, Saratoga, Calif., Hugh Holbrook, San Francisco, and Fusun Ertemalp, Palo Alto, Calif., for a "system and method for managing bandwidth." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system for managing bandwidth use in a device. In a specific embodiment, the device is a network device that includes a first data scheduler that is adapted to initially share available device bandwidth among a first type of traffic and a second type of traffic on an as-needed basis. A traffic monitor communicates with the first scheduler and causes the first data scheduler to guarantee predetermined transmission characteristics for the second type of traffic. The first data scheduler includes one or more routines for prioritizing first type of traffic above the second type of traffic when the network device is in a first operational mode, and prioritizing the second type of traffic above the first type of traffic when the network device is in a second operation al mode. The minimum transmission characteristics include a minimum service rate and a minimum latency for the second type of traffic." The patent application was filed on Sept. 19, 2006 (11/523,335). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,219.PN.&OS=PN/83,69,219&RS=PN/83,69,219 Written by Amal Ahmed; edited by Jaya Anand.

*** Avaya Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Avaya, Basking Ridge, N.J., has been assigned a patent (8,369,220) developed by five co-inventors for "routing a flow of elastic traffic." The co-inventors are Bakul Khanna, Lexington, Mass., Jozef Babiarz, Kanata, Canada, Ali Labed, Ottawa, Delfin Montuno, Kanata, Canada, and Hesham El-Bakoury, San Jose, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "To route a flow of elastic traffic, plural candidate paths are identified for the flow of elastic traffic. A particular path from among the plural candidate paths is selected to route the flow of elastic traffic according to criteria including numbers of flows on respective candidate paths and measured performances of the respective candidate paths." The patent application was filed on Dec. 31, 2007 (12/006,128). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,220.PN.&OS=PN/83,69,220&RS=PN/83,69,220 Written by Amal Ahmed; edited by Jaya Anand.

*** Abbott Cardiovascular Systems Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Abbott Cardiovascular Systems, Santa Clara, Calif., has been assigned a patent (8,366,664) developed by Jesus Magana, Redwood City, Calif., for an "agent delivery catheter having articulating arms." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An agent delivery catheter which has a support member comprising at least one articulating arm having an end fixedly secured relative to the shaft and having an anchor end section opposite to the fixed end. The articulating arm is biased to pivot at the fixed end away from the shaft, to transform from a low profile configuration to a high profile configuration in which the arm extends laterally away from the shaft and the anchor end section contacts the patient's body lumen wall, to support the shaft in the body lumen during delivery of an agent, for example by injection from a needle extended from the catheter into the wall of the body lumen." The patent application was filed on Sept. 19, 2011 (13/236,392). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,664.PN.&OS=PN/83,66,664&RS=PN/83,66,664 Written by Amal Ahmed; edited by Jaya Anand.

*** Cardiac Pacemakers Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Cardiac Pacemakers, St. Paul, Minn., has been assigned a patent (8,366,641) developed by Hua Wang, Pasadena, Calif., and John Hatlestad, Maplewood, Minn., for a "posture detector calibration and use." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Calibrating a posture detector for a patient's body involves measuring outputs of one or more sensors disposed in relation to the patient's body while the patient assumes a plurality of positions. A transfer matrix is formed having coefficients corresponding to the measured outputs. The transfer matrix defines a relationship between a coordinate system of the one or more sensors and a coordinate system of the patient's body. The body coordinate system is used as a reference coordinate system for posture detection. Posture, including tilt and/or tilt angle, may be determined based on first and second rotational angles defined in relation to the body coordinate system." The patent application was filed on Nov. 18, 2005 (11/283,490). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,641.PN.&OS=PN/83,66,641&RS=PN/83,66,641 Written by Amal Ahmed; edited by Jaya Anand.

*** Codan U.S. Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Codan U.S., Santa Ana, Calif., has been assigned a patent (8,366,697) developed by Thomas F. Knight, Trabuco Canyon, Calif., for an "enteral feeding safety reservoir and system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides a one-piece bottle containing enteral feeding material and having a top end with a threaded section and a bottom end comprising a funneled connector port; and a threaded cap dimensioned to mate with the threaded section of the one-piece bottle; wherein the funneled connector port connects to an enteral feeding assembly; wherein the threaded cap provides a leak proof seal such that there is no exposure point until it is used for feeding, thereby preventing contamination." The patent application was filed on Jan. 20, 2010 (12/690,845). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,697.PN.&OS=PN/83,66,697&RS=PN/83,66,697 Written by Amal Ahmed; edited by Jaya Anand.

*** Transderm Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Transderm, Santa Cruz, Calif., has been assigned a patent (8,366,677) developed by Roger L. Kaspar, Santa Cruz, Calif., and Tycho Speaker, Santa Cruz, Calif., for "microneedle arrays formed from polymer films." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides for transdermal delivery devices having microneedle arrays, as well as methods for their manufacture and use. In one embodiment, a transdermal delivery device is provided. The transdermal delivery device includes a polymer layer which has microneedles projecting from one of its surfaces. The microneedles are compositionally homogenous with the polymer base layer." The patent application was filed on Aug. 6, 2008 (12/187,268). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,677.PN.&OS=PN/83,66,677&RS=PN/83,66,677 Written by Amal Ahmed; edited by Jaya Anand.

*** Verizon Patent and Licensing Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Verizon Patent and Licensing, Basking Ridge, N.J., has been assigned a patent (8,369,222) developed by Deepak Kakadia, Union City, Calif., Jay J. Lee, San Ramon, Calif., and Thomas H. Tan, San Jose, Calif., for a "system and method for multi-layer network analysis and design." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Techniques for providing a method and system for multi-layer network analysis and design are disclosed. In one particular exemplary embodiment, the techniques may be realized as a method, comprising determining, using a computer model of a network, a minimum probability of failure path between a pair of network nodes at a first network layer for one or more pairs of network nodes, calculating, using a processor and stored network data, a value for the minimum probability of failure for the identified minimum probability of failure path between the pair of network nodes at the first network layer for the one or more pairs of network nodes. The method may include identifying a maximum of the determined minimum probability of failure values for the one or more pairs of network nodes for the first network layer. The method may include probability of failure calculations for one or more secondary network layers." The patent application was filed on Oct. 8, 2010 (12/901,157). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,222.PN.&OS=PN/83,69,222&RS=PN/83,69,222 Written by Amal Ahmed; edited by Jaya Anand.

*** Progressive Lighting and Radiometrics Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Progressive Lighting and Radiometrics, Haddonfield, N.J., has been assigned a patent (8,366,755) developed by George Brainard, Haddonfield, N.J., and Gena Glickman, San Diego, for a "photoreceptor system for melatonin regulation and phototherapy." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention involves a light system for stimulating or regulating neuroendocrine, circadian, and photoneural systems in mammals based upon the discovery of peak sensitivity ranging from 425-505 nm; a light meter system for quantifying light which stimulates or regulates mammalian circadian, photoneural, and neuroendocrine systems. The present invention also relates to translucent and transparent materials, and lamps or other light sources with or without filters capable of stimulating or regulating neuroendocrine, circadian, and photoneural systems in mammals. Additionally, the present invention involves treatment of mammals with a wide variety of disorders or deficits, including light responsive disorders, eating disorders, menstrual cycle disorders, non-specific alerting and performance deficits, hormone-sensitive cancers, and cardiovascular disorders." The patent application was filed on Jan. 22, 2010 (12/657,533). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,755.PN.&OS=PN/83,66,755&RS=PN/83,66,755 Written by Amal Ahmed; edited by Jaya Anand.

*** Micrus Endovascular Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Micrus Endovascular, San Jose, Calif., has been assigned a patent (8,366,738) developed by Houdin Dehnad, El Granada, Calif., for a "tethered coil for treatment of body lumens." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed is an apparatus and a method for removable of undesired material from body lumens. The apparatus may be used for fragmenting or removing a thrombus or occlusion from a blood vessel. The apparatus includes first shape segments and second shape segments connected to form a coiled member. A longitudinally extending tether is positioned inside the first shape segments and outside the second shape segments along the length of the coil. Applying a proximal force on the tether produces a change in the shape of at least a portion of the coil from a first generally linear configuration to a second complex three dimensional shape. A method of using the apparatus to engage and remove, or fragment, the thrombus or occlusion is disclosed." The patent application was filed on Sept. 23, 2011 (13/243,744). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,738.PN.&OS=PN/83,66,738&RS=PN/83,66,738 Written by Amal Ahmed; edited by Jaya Anand.

*** Abbott Cardiovascular Systems Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Abbott Cardiovascular Systems, Santa Clara, Calif., has been assigned a patent (8,366,737) developed by six co-inventors for an "expandable emboli filter and thrombectomy device." The co-inventors are David Hancock, San Francisco, William S. Tremulis, Redwood City, Calif., Saypin Phonthalasa, San Francisco, Olin Palmer, Mountain View, Calif., Larry Voss, San Jose, Calif., and Gary A. Walker, Fremont, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Expandable emboli filter and thrombectomy devices adapted for use with microcatheters to remove debris from blood vessels. The devices embody expanded profiles that span the entirety of various sized target vessels and thus are particularly effective in the engagement of debris found in vessels." The patent application was filed on Aug. 25, 2010 (12/868,558). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,737.PN.&OS=PN/83,66,737&RS=PN/83,66,737 Written by Amal Ahmed; edited by Jaya Anand.

*** Biolase Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Biolase, Irvine, Calif., has been assigned a patent (8,366,702) developed by Marcia Angela Van Valen, Aliso Viejo, Calif., for "methods for treating hyperopia and presbyopia via laser tunneling." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance." The patent application was filed on Dec. 21, 2010 (12/975,202). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,702.PN.&OS=PN/83,66,702&RS=PN/83,66,702 Written by Amal Ahmed; edited by Jaya Anand.

*** Tympany Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Tympany, The Woodlands, Texas, has been assigned a patent (8,366,632) developed by four co-inventors for "stenger screening in automated diagnostic hearing test." The co-inventors are Aaron R. Thornton, West Des Moines, Iowa, Jeffrey S. Harrison, Palo Alto, Calif., Christopher L. Wasden, New Canaan, Conn., and Barry Strasnick, Virginia Beach, Va.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Method and system are disclosed for automated testing of a patient's hearing. The automated hearing test allows the patient to quickly and accurately test his own hearing. The patient is instructed and prompted for inputs and responses as needed. The patient and/or operator can select one or several tests to be performed, including air and bone conduction testing with masking, speech reception threshold, speech discrimination, tympanogram, acoustic reflex, and otoacoustic emissions testing. Stenger screening is automatically performed for some patients based on the difference in pure tone frequency air conduction thresholds. Multiple languages are supported. Data obtained from one test may be used for another test or another iteration of the same test to calculate masking levels. The automatic hearing test also detects and compensates for ambient noise in the test results. If a contingency occurs, the automated hearing test is configured to page the operator for assistance." The patent application was filed on Dec. 19, 2008 (12/340,403). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,632.PN.&OS=PN/83,66,632&RS=PN/83,66,632 Written by Amal Ahmed; edited by Jaya Anand.

*** Baxano Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Baxano, San Jose, Calif., has been assigned a patent (8,366,712) developed by Jeffery L. Bleich, Palo Alto, Calif., Michael Sheinberg, Diablo, Calif., and Michael P. Wallace, Pleasanton, Calif., for "multiple pathways for spinal nerve root decompression from a single access point." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method of accessing target tissue adjacent to a spinal nerve of a patient includes the steps of accessing a spine location of the patient by entering the patient through the skin at an access location, inserting a flexible tissue modification device through the access location to the spine location, advancing a distal portion of the first flexible tissue modification device from the spine location to a first exit location, passing through the first exit location and out of the patient, advancing the first or a second flexible tissue modification device through the same access location to the spine location and to a second exit location, and passing through the second exit location and out of the patient." The patent application was filed on Dec. 6, 2011 (13/312,272). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,712.PN.&OS=PN/83,66,712&RS=PN/83,66,712 Written by Amal Ahmed; edited by Jaya Anand.

*** Silver Spring Networks Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Silver Spring Networks, Redwood City, Calif., has been assigned a patent (8,369,216) developed by Daniel D. Kan, San Jose, Calif., for a "system and method of monitoring packets in flight for optimizing packet traffic in a network." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Systems and methods of optimizing packet flow in a network are disclosed. An internetwork has a first network and plural second networks. A respective packet-in-flight counter is established for each one of the plural second networks and a respective maximum packet-in-flight indication for each one of the plural second networks. The respective packet-in-flight counter for each one of the plural second networks when a request packet is sent from any node in the first network to any node in that one of the plural second networks, or a response packet is received from any node that one of the plural second networks. it is determined whether a second request packet can be sent from any node in the first network to any of the plurality of nodes in one of the plural second networks, based on processing a value of the respective packet-in-flight counter for that one of the plural second networks and a value of the respective maximum packet-in-flight indication for that one of the plural second networks. The respective maximum packet-in-flight indication for each one of the plural second networks is adjusted based on a statistic that is indicative of roundtrip time for request packets sent from any node of the first network to any of the plurality of nodes in that one of the plural second networks." The patent application was filed on Oct. 19, 2010 (12/907,047). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,69,216.PN.&OS=PN/83,69,216&RS=PN/83,69,216 Written by Amal Ahmed; edited by Jaya Anand.

*** Abbott Medical Optics Assigned Patent for Vacuum Sense Control for Phaco Pulse Shaping ALEXANDRIA, Va., Feb. 9 -- Abbott Medical Optics, Santa Ana, Calif., has been assigned a patent (8,366,728) developed by James W. Staggs, Laguna Niguel, Calif., for a "vacuum sense control for phaco pulse shaping." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and apparatus for precisely controlling particle movement relative to a phacoemulsification needle tip is provided. The design monitors actual vacuum present and calculates a pulse shape amplitude waveform proportional to the amount of measured vacuum. An increase in vacuum indicates that the handpiece/needle is becoming occluded by a large particle. The present design determines whether additional power is required to bump or move a large particle away from the needle tip. The present design may employ a control loop that senses and continuously monitors vacuum. The design may dynamically vary the amount of ultrasonic energy delivered to the surgical area in response to the observed actual vacuum, and can actively vary the amount of power delivered to the surgical area based on the size of the particle and the resultant vacuum realized." The patent application was filed on May 17, 2012 (13/473,959). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,728.PN.&OS=PN/83,66,728&RS=PN/83,66,728 Written by Amal Ahmed; edited by Jaya Anand.

*** Micrus Assigned Patent ALEXANDRIA, Va., Feb. 9 - Micrus, Mountain View, Calif., has been assigned a patent (8,366,665) developed by Peter Wilson, Foster City, Calif., Eric Leopold, Redwood City, Calif., and Rupesh K. Desai, San Jose, Calif., for a "stretch resistant therapeutic device." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A vasoocclusive coil is reinforced with a stretch resistant member to improve safety during retraction of the coil. The stretch resistant member is fixedly attached at one end to the vasoocclusive coil, and the other end of the stretch resistant member is detachably mounted to an elongated pusher member to allow for placement and release of the vasoocclusive coil within the patient's vasculature." The patent application was filed on Feb. 15, 2008 (12/032,254). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,665.PN.&OS=PN/83,66,665&RS=PN/83,66,665 Written by Amal Ahmed; edited by Jaya Anand.

*** Cabochon Aesthetics Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Cabochon Aesthetics, Menlo Park, Calif., has been assigned a patent (8,366,643) developed by Mark E. Deem, Mountain View, Calif., Hanson S. Gifford III, Woodside, Calif., and Douglas S. Sutton, Pacifica, Calif., for a "system and method for treating subcutaneous tissues." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An apparatus and method for treating subcutaneous tissues using acoustic waves in the range of low acoustic pressure ultrasound waves is disclosed. The method includes injections of enhancing agents, wherein disruption of subcutaneous tissues and subcutaneous cavitational bioeffects are produced by ultrasound waves having a power that will not produce tissue cavitation in the absence of the enhancing agents. The apparatus and method of use is useful for treatment of subcutaneous abnormalities including cellulite, lipomas, and tumors." The patent application was filed on Sept. 14, 2009 (12/559,448). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,643.PN.&OS=PN/83,66,643&RS=PN/83,66,643 Written by Amal Ahmed; edited by Jaya Anand.

*** Covidien Assigned Patent for LED Drive Circuit for Pulse Oximetry and Method for Using Same ALEXANDRIA, Va., Feb. 9 -- Covidien, Mansfield, Mass., has been been assigned a patent (8,366,613) developed by Ethan Petersen, Oakland, Calif., for an "LED drive circuit for pulse oximetry and method for using same." The abstract of the patent published by the U.S. Patent and Trademark Office states: "In various embodiments, there is provided an LED drive circuit and a method for using the same. Specifically, the present disclosure is directed to an LED drive circuit for pulse oximeters. In an embodiment, the LED drive circuit includes a current mirror configured to provide drive current to an LED of a sensor. Additionally, the method includes providing current to first and second current mirrors, wherein the first and second current mirrors are configured to control first and second light sources." The patent application was filed on Dec. 24, 2008 (12/343,799). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,613.PN.&OS=PN/83,66,613&RS=PN/83,66,613 Written by Amal Ahmed; edited by Jaya Anand.

*** University of California Assigned Patent ALEXANDRIA, Va., Feb. 9 -- The University of California, Oakland, Calif., has been assigned a patent (8,366,758) developed by Thomas E. Ahlering, Laguna Niguel, Calif., and David S. Finley, Long Beach, Calif., for a "hypothermia for improving rate of functional recovery following pelvic surgeries." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Hypothermia significantly improves the rate of recovery of function following abdominal surgery--particularly radical prostatectomy. Prior to commencing surgery the tissues at and surrounding the site of the surgery are cooled by means of an endorectal cooling balloon inserted into the patient's rectum. The uninflated balloon is inserted and then inflated with cooling fluid which fluid is constantly circulated in and out to lower the temperature. Improved hypothermia can be achieved by bathing internal tissue with chilled water or buffer. Limitation of surgically induced damage can be demonstrated by the more rapid regain of continence in radical prostatectomy patients treated with hypothermia during surgery." The patent application was filed on Feb. 11, 2009 (12/867,247). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,758.PN.&OS=PN/83,66,758&RS=PN/83,66,758 Written by Amal Ahmed; edited by Jaya Anand.

*** University of Washington Assigned Patent ALEXANDRIA, Va., Feb. 9 -- The University of Washington, Seattle, has been assigned a patent (8,366,619) developed by five co-inventors for "nodule screening using ultrasound elastography." The co-inventors are Yongmin Kim, Lake Forest Park, Wash., Manjiri Dighe, Bellevue, Wash., Si Luo, Seattle, Jae Kim, Torrance, Calif., and Eung-Hun Kim, Bothell, Wash.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A medical device is configured to diagnose whether a nodule of a bodily organ is malignant or benign using ultrasound elastography to determine a nodule stiffness index. Using either an external compression source or an in vivo pulsation source, the stiffness of the nodule of the bodily organ can be quantified by either its static properties or dynamic properties. The nodule can be classified as Type I, which is benign requiring further observation, or Type II, which is malignant requiring invasive procedures." The patent application was filed on May 13, 2010 (12/779,903). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,66,619.PN.&OS=PN/83,66,619&RS=PN/83,66,619 Written by Amal Ahmed; edited by Jaya Anand.

*** Harbor Therapeutics Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Harbor Therapeutics, San Diego, has been assigned a patent (8,367,646) developed by James M. Frincke, San Diego, for "steroid compounds and treatment methods." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides methods to treating conditions such as prostate cancer, or for ameliorating one or more symptoms associated with prostate cancer, or for agents that modulate the biological activity of the androgen receptor. The invention also provides methods and compositions suitable for therapeutic applications." The patent application was filed on Nov. 29, 2011 (13/306,141). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,646&OS=8,367,646&RS=8,367,646 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Allergan Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Allergan, Irvine, Calif., has been assigned a patent (8,367,664) developed by Xialing Guo, San Clemente, Calif., Zhen Zhu, Foothill Ranch, Calif., and Thomas C. Malone, Irvine, Calif., for a "substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation." The patent application was filed on Jan. 23, 2007 (11/625,852). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,664&OS=8,367,664&RS=8,367,664 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Arena Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Arena Pharmaceuticals, San Diego, has been assigned a patent (8,367,657) developed by eight co-inventors for "processes for preparing 3-benzazepines." The co-inventors are Beverly L. Wolgast, San Diego, Charles A. Gilson III, San Diego, Shelley Aytes, San Diego, Scott A. Estrada, La Jolla, Calif., Dipanjan Sengupta, San Diego, Brian Smith, San Diego, Max Rey, Wallisellen, Switzerland, and Ulrich Weigl, Hilzingen, Germany.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides processes and intermediates for the preparation of 3-benzazepines and salts thereof which can be useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity." The patent application was filed on June 16, 2004 (10/560,953). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,657&OS=8,367,657&RS=8,367,657 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Kythera Biopharmaceuticals Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Kythera Biopharmaceuticals, Calabasas, Calif., has been assigned a patent (8,367,649) developed by Robert Emil Hodge, Thousand Oaks, Calif., and Jeffrey Douglas Webster, Thousand Oaks, Calif., for "formulations of deoxycholic acid and salts thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5." The patent application was filed on Dec. 12, 2011 (13/323,605). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,649&OS=8,367,649&RS=8,367,649 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Gilead Sciences Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Gilead Sciences, Foster City, Calif., has been assigned a patent (8,367,670) developed by seven co-inventors for "modulators of toll-like receptors." The co-inventors are Manoj C. Desai, Pleasant Hill, Calif., Randall L. Halcomb, Foster City, Calif., Paul Hrvatin, South San Francisco, Calif., Hon Chung Hui, San Mateo, Calif., Ryan McFadden, Foster City, Calif., Paul A. Roethle, San Francisco, and Hong Yang, Fremont, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided are modulators of TLRs of Formula II: ##STR00001## pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds." The patent application was filed on Dec. 7, 2009 (12/632,194). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,670&OS=8,367,670&RS=8,367,670 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Achaogen Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Achaogen, South San Francisco, Calif., has been assigned a patent (8,367,625) developed by eight co-inventors for antibacterial aminoglycoside analogs. The co-inventors are James Bradley Aggen, Burlingame, Calif., Martin Sheringham Linsell, San Mateo, Calif., Adam Aaron Goldblum, Berkeley, Calif., Darin James Hildebrandt, Mountain View, Calif., Timothy Robert Kane, Moss Beach, Calif., Paola Dozzo, San Francisco, Micah James Gliedt, Sunnyvale, Calif., and Heinz Ernst Moser, San Mateo, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): ##STR00001## including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q.sub.1, Q.sub.2, R.sub.1, R.sub.2 and R.sub.3 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed." The patent application was filed on April 7, 2011 (13/082,141). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,625&OS=8,367,625&RS=8,367,625 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Burnham Institute Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Burnham Institute, La Jolla, Calif., has been assigned a patent (8,367,644) developed by John C. Reed, Rancho Sante Fe, Calif., and Maurizio Pellecchia, San Diego, for "methods and compounds useful to induce apoptosis in cancer cells." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides a method for treating cancer in a mammal comprising contacting the cancer cells with a compound which is a apogossypol, derivative." The patent application was filed on May 27, 2005 (12/900,319). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,644&OS=8,367,644&RS=8,367,644 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Tetraphase Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Tetraphase Pharmaceuticals, Watertown, Mass., has been assigned a patent (8,367,654) developed by five co-inventors for 8-AZA tetracycline compounds. The co-inventors are Roger B. Clark, Lexington, Mass., Minsheng He, Watertown, Mass., Louis Plamondon, Belmont, Mass., Xiao-Yi Xiao, San Diego, and Magnus P. Ronn, Melrose, Mass.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use. ##STR00001##." The patent application was filed on May 7, 2010 (13/319,307). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,654&OS=8,367,654&RS=8,367,654 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Sanford-Burnham Medical Research Institute Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Sanford-Burnham Medical Research Institute, La Jolla, Calif., has been assigned a patent (8,367,621) developed by Erkki Ruoslahti, Buellton, Calif., Tambet Teesalu, Goleta, Calif., and Kazuki Sugahara, Goleta, Calif., for "methods and compositions related to internalizing RGD peptides." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed are compositions and methods useful for targeting tissue undergoing angiogenesis or to cells or tissue expressing .alpha.v integrins. The compositions and methods are based on peptide sequences that selectively bind to and home to tissue undergoing angiogenesis or to cells or tissue expressing .alpha.v integrins in animals. The disclosed targeting is useful for delivering therapeutic and detectable agents to tissue experiencing angiogenesis or to cells or tissue expressing .alpha.v integrins." The patent application was filed on Jan. 16, 2009 (12/355,672). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,367,621&OS=8,367,621&RS=8,367,621 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Exelixis Assigned Patent ALEXANDRIA, Va., Feb. 9 -- Exelixis, South San Francisco, Calif., has been assigned a patent For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1113874 (c) 2013 Targeted News Service

[ Back To Technology News's Homepage ]